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We describe an unusual element that activates the synthesis of short transcripts from a wide variety of mRNA 
and small nuclear RNA (snRNA) promoters, including the U6 RNA polymerase III promoter. This inducer of 
short transcripts (1ST) is located between positions - 5 and +82 relative to the cap site in the HIV-1 LTR. In 
the presence of 1ST, the total transcriptional activity of the different promoters is greatly increased, but the 
resulting additional RNA molecules are short, ending around position + 60.1ST is not the RNA target (TAR) for 
Tat trans-activation; however, because it relies entirely on cellular factors for activity, 1ST may serve to provide 
abundant RNA targets for Tat trans-activation without a requirement for full-length viral mRNA expression. 
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In several transcription units, including the SV40 and 
adenovirus 2 (Ad2) major late transcription units, the 
c-myc gene, the Drosophila hspJO gene, and the HIV-1 
long terminal repeat (LTR), some transcription is con-
fined under certain circumstances to the region prox-
imal to the promoter (for review, see Spencer and Grou-
dine 1990). In the cases where the products of such 
transcription are stable enough to be detectable in 
steady-state RNA, they are found to consist of short, 
nonpolyadenylated RNA molecules. Very little is 
known about the mechanisms that govern the formation 
of these short transcripts or about the role of the short 
transcripts themselves. In HIV-1, however, it is likely 
that the short transcripts provide the target for trans-ac-
tivation by the viral protein Tat. 
Tat is a potent trdus-activator of HIV-1 gene expres-
sion and functions at least in part by increasing the 
amounts of HIV-1 mRNAs at the level of transcription 
(Hauber et al. 1987; Kao et al. 1987; Jakobovits et al. 
1988; Rice and Mathews 1988; Sadaie et al. 1988). Tat 
affects both initiation and elongation of transcription 
(Laspia et al. 1989), although some assays detect only the 
effect on elongation (Kao et al. 1987). Tat is unusual in 
that it acts through an RNA element, the trans-activa-
tion response (TAR) element (Feng and Holland 1988; 
Berkhout et al. 1989; Selby et al. 1989; Roy et al. 1990; 
Southgate et al. 1990; Selby and Peterlin, 1990) encoded 
by sequences downstream of the HIV-1 mRNA initia-
tion site, between nucleotides -1-18 and +44 (Rosen et 
al. 1985; Hauber and Cullen 1988; Jakobovits et al. 1988; 
Selby et al. 1989). The TAR element corresponds to the 
upper half of a bulged stem-and-loop structure that ex-
tends from nucleotides -t-1 to -1-59 (Muesing et al. 1987). 
The short transcripts encompass this structure, ex-
tending from nucleotide -t-1 to about -I- 60, and are more 
abundant in the absence than in the presence of Tat (Kao 
et al. 1987). 
How are the short transcripts generated? There is 
clearly no universal block to transcription around posi-
tion -I- 60, because deletion or insertion of the R region 
of the HIV-1 LTR into other transcription units does not 
have any effect on gene expression (Rosen et al. 1985; 
Cullen 1986; Peterlin et al. 1986; Wright et al. 1986; 
Muesing et al. 1987; Hauber and Cullen 1988). Instead, 
the HIV-1 promoter might direct the formation of tran-
scription complexes unable to elongate transcription ef-
ficiently; the short transcripts would then be the rem-
nants, stabilized by the binding of cellular proteins 
to the stem-and-loop structure (Gatignol et al. 1989; 
Gaynor et al. 1989; Marciniak et al. 1990), of longer ran-
domly terminated RNA molecules. Indeed, in the 
human c-myc and perhaps the Drosophila hsplO genes, 
events occurring at the promoter can influence the elon-
gation properties of the transcription complex (Bentley 
and Groudine 1988; Rougvie and Lis 1988; Spencer et al. 
1990; for review, see Spencer and Groudine 1990). 
Perhaps the best-characterized examples of interde-
pendence between promoter and terminator sequences 
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are the human Ul and U2 small nuclear RNA (snRNA) 
genes, whose normal products are also short, nonpolya-
denylated RNAs. U-snRNAs are involved in RNA pro-
cessing (for review, see Steitz et al. 1988) and, except for 
U6, which is synthesized by RNA polymerase III from 
an unusual promoter located in the 5'-flanking sequence 
of the gene (Das et al. 1988), the snRNAs are synthesized 
by RNA polymerase II (for review, see Dahlberg and 
Lund 1988). The RNA polymerase II snRNA promoters 
direct the formation of specialized transcription com-
plexes that, unlike mRNA transcription complexes, are 
capable of recognizing a termination signal called the 3' 
box, located just downstream of the genes (for review, 
see Dahlberg and Lund 1988; Hernandez and Lucito 
1988; Neuman de Vegvar and Dahlberg 1989). Further-
more, these specialized snRNA transcription complexes 
are not capable of efficient elongation, because in the 
absence of the 3' box they terminate heterogeneously 
at nearby downstream cryptic 3' boxes that sometimes 
bear little resemblance to the authentic signal (Neuman 
de Vegvar et al. 1986). Thus, here, the fate of a transcrip-
tion complex with regard to elongation and termination 
is determined at the promoter. 
To determine whether formation of short transcripts 
in the HIV-1 transcription unit is also dependent on pro-
moter sequences, we have tested a series of hybrid con-
structs in which the HIV-1 promoter sequences are re-
placed by other mRNA and snRNA promoters. These 
experiments have led us to the discovery of a novel ele-
ment, located between positions - 5 and + 82 relative to 
the transcription initiation site in the HIV-1 LTR, that 
activates the synthesis of short transcripts from every 
promoter we have tested including the U2 and the RNA 
polymerase III U6 promoters. We call this element 1ST, 
for inducer of short transcripts. In our assay, 1ST does 
not interfere significantly with the basal production of 
full-length transcripts from the various promoters, but 
instead superimposes itself on the normal promoter 
activity to make additional short transcripts. Hence, 
mRNA synthesis is not increased significantly although 
the promoter is much more active. Mutations that inac-
tivate TAR do not affect 1ST function, showing that 
these are two different elements. Because 1ST relies en-
tirely on cellular factors for function, it is likely to have 
cellular counterparts and may be an example of a new 
category of regulatory elements that affect transcription 
both at the level of initiation and of elongation. 
Results 
Experimental design 
To examine directly the amounts of short and long 
RNAs produced from the HIV-1 promoter, we designed a 
transcription unit short enough so that both short and 
long transcripts could be easily probed over their entire 
length by RNase Ti mapping. This "mini" transcription 
unit, pHIV-l/R, is shown in Figure lA. It contains HIV-1 
sequences from -138 to +82 relative to the cap site 
(+ 1), and thus comprises the HIV-1 promoter region as 
well as nearly the entire R region of the HIV-1 LTR, in-
cluding the sequences encoding the TAR RNA element. 
Immediately downstream of the R region is a fragment 
derived from Ad2 that contains the L3 polyadenylation 
signal. Farther downstream, we inserted an antisense 
bacteriophage T3 promoter such that perfectly comple-
mentary riboprobes could be synthesized easily from 
this and all subsequent constructs described below. 
pHIV-l/R also carries the SV40 origin of replication, so 
that its copy number can be increased where necessary 
by coexpression of SV40 T antigen (T Ag). 
To characterize the pHIV-l/R transcription unit, this 
vector was transfected into Jurkat T cells, a host for 
HIV-1 replication, together with a construct expressing 
the Tat protein or a similar construct lacking the Tat-
coding sequences. A plasmid containing the human a-
globin gene, a gene not responsive to Tat, was included 
as an internal reference in this and all subsequent trans-
fections. RNA extracted from the transfected cells was 
analyzed by RNase Tj protection mapping with a mix-
ture of two probes—probe a98, which is protected over 
98 nucleotides by correctly initiated a-globin RNA, and 
either probe T3/534 or probe T3/358 (Fig. lA). Probe 
T3/534 extends from downstream of the polyadenyla-
tion site to upstream of the start site of transcription and 
therefore simultaneously maps the 5' and 3' ends of cor-
rectly initiated and polyadenylated RNA molecules (Fig. 
lA). Probe T3/358 is truncated at position -1-22 down-
stream of the HIV-1 transcriptional start site and should, 
therefore, give rise to fragments 22 nucleotides shorter 
than probe T3/534 upon protection by correctly initiated 
HIV-1 RNA (Fig. lA). 
The patterns obtained in such an analysis are shown 
in Figure IB. The constant intensity of the a-globin 
signal (labeled a] shows that the transfection efficiencies 
and RNA recoveries were very similar in each pair of 
samples. The bands labeled RT, L3, and st all correspond 
to RNA correctly initiated at the HIV-1 cap site, because 
the RNAs were shortened by the expected length when 
the T3/358 probe was used (cf. lanes 1 and 2 with lanes 3 
and 4). The lengths of these different protected frag-
ments indicate that the band labeled RT corresponds to 
RNA reading through the L3 polyadenylation site, L3 
corresponds to RNA polyadenylated at the L3 site, and 
the bands labeled st correspond to short RNAs ending 
heterogeneously downstream of the stem-and-loop 
structure, around position +60. Fractionation of the 
RNAs over oligo(dT)-cellulose columns confirmed that 
the L3 RNA is polyadenylated, whereas the RT and st 
transcripts are not polyadenylated (data not shown). The 
bands labeled st seemed, then, to correspond to the short 
transcripts observed by Kao et al. (1987); however, these 
bands could also result from artifactual RNase Tj 
cleavage of the probe in the RNA-RNA hybrids around 
position +60. To exclude this possibility, we replaced 
the HIV-1 promoter in pHIV-l/R by the bacteriophage 
T7 promoter and synthesized unlabeled RNA extending 
through the whole transcription unit with bacteriophage 
T7 RNA polymerase. This RNA was then hybridized to 
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Figure 1. Short transcripts are generated in Jurkat cells. [A] Structure of 
the hybrid gene insert in pHIV-l/R. HIV-1 sequences extend from - 138 to 
+ 82 and include the HIV-1 promoter with the enhancer (ENH), the three 
Spl-binding sites and the TATA box, and R sequences from +1 to +82 
(wavy line), including the sequences encoding the TAR element. Down-
stream is an Ad2 fragment (large box) containing a polyadenylation site 
(pA), followed by a fragment carrying the bacteriophage T3 promoter. The 
structures of the two RNA probes (T3/534 and T3/358) are indicated (open 
boxes), together with the lengths of the protected fragments corresponding 
to short RNAs or polyadenylated RNAs. [B] (Lanes 1-4] RNase Ti analysis 
of RNA isolated from Jurkat cells transfected with a plasmid (palx72) car-
rying the a-globin internal reference gene, the pHIV-l/R construct, and a 
Tat expression vector (pCGTat) (lanes +) or the same vector without the 
Tat-coding sequences (pCG) (lanes - ) . The probes used were the a98 probe, 
which protects correctly initiated a-globin RNA over 98 nucleotides, to-
gether with the probes indicated above the lanes. In lane 5, the RNA used 
for the RNase Ti mapping was generated in vitro with bacteriophage T7 
RNA polymerase, from a template (pT7/R) in which the HIV-1 promoter 
had been replaced by the T7 promoter, (a) Correctly initiated a-globin 
RNA; (st) correctly initiated short transcripts; (L3) RNA correctly initiated 
and polyadenylated at the L3 site; (RT) RNA correctly initiated and reading 
through the L3 polyadenylation site. RNase Tj digestion of the probe hy-
bridized to RNA from mock-transfected cells generated only products with 
much higher mobility than the st bands. 
B. 
'^ CD ' ' ^ f 
ro iT) fO 
uD ro in 
•-s. ^ " v 
fO rO ro 
I— —^ t~ 
pMiV-I/R 
1 fr 
L3 
o<-
st titm 
12 3 4 ,5 
the antisense probe T3/534, and the hybrids were treated 
with RNase Tj under the same conditions as the 
samples in lanes 1 and 2. As shown in lane 5, RNase Tj 
mapping of this RNA with probe T3/534 protected the 
entire RNA molecule and did not generate any short 
fragments, demonstrating that the short fragments de-
tected with RNA from transfected cells correspond to 
molecules ending around position +60. 
In the presence of Tat (Fig. IB, lanes 2 and 4), there 
was a slight decrease in the amounts of short transcripts, 
together with an increase in the amounts of polyadenyl-
ated RNA. Surprisingly, the amounts of correctly initi-
ated RNA reading through the polyadenylation site (RT 
transcripts) were not increased in the presence of Tat. 
This observation is reproducible and may indicate that 
these transcripts are synthesized aberrantly in a nuclear 
compartment devoid of polyadenylation and Tat trans-
activation machinery. Nevertheless, the experiment in 
Figure 1 shows that the pHIV/R transcription unit can 
be used to map simultaneously short and long tran-
scripts in their entirety and that it responds to Tat 
trans-sictiysition. The patterns of short and long tran-
scripts in the presence and absence of Tat in Jurkat T 
cells are consistent with the results of Kao et al. (1987) 
in COS cells. 
To determine the role of the HIV-1 promoter se-
quences in the formation of short transcripts, we con-
structed several derivatives of the parent pHIV-l/R con-
struct in which the FIIV-1 promoter was exchanged for 
other mRNA promoters, for the U2 snRNA promoter, 
which is known to direct the formation of a transcrip-
tion complex with different elongation properties, and 
for the RNA polymerase III U6 promoter. RNA expres-
sion from the different constructs was monitored by 
RNase Ti mapping and run-on experiments. The con-
structs were tested, whenever possible, in Jurkat cells, a 
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T-cell line, because T cells are a target for HIV-1 infec-
tion. Some promoters were not expressed efficiently in 
Jurkat cells, however, and were therefore tested in HeLa 
cells, in some cases in the presence of SV40 T Ag to am-
plify the signal. The run-on experiments were all per-
formed in COS cells, because amplification of the tem-
plates was more efficient than in HeLa cells cotrans-
fected with a T Ag expression vector. However, the 
results in all the cell lines were qualitatively identical. 
Below, we first show that formation of short tran-
scripts is not dependent on the HIV-1 promoter, but in-
stead that the HIV-1 sequences between - 5 and -1-82 
induce the formation of short transcripts when located 
downstream of different mRNA promoters, the U2 pro-
moter, and even the U6 promoter. We then show by run-
on analyses that induction of the short transcripts corre-
lates with an increase in transcription. 
Short tiansciipts are synthesized from all tested mRNA 
promoters fused to HIV-1 sequences from positions -5 
to +82 
To determine whether the formation of short transcripts 
is mRNA promoter dependent, we tested constructs in 
which the HIV-1 promoter was replaced by the (i-globin 
promoter (pPgl/R), the Ad2 major late promoter (pMLP/ 
R), and the a-globin promoter (pagl/R) (Fig. 2A). Figure 
2B shows the patterns obtained after transfection into 
HeLa cells. As observed in Jurkat cells, the wild-type 
construct, pHIV-l/R, generated mainly short transcripts 
in the absence of Tat (lane 1). In the presence of Tat, the 
amounts of short transcripts were decreased signifi-
cantly and polyadenylated RNA was increased ~40-fold, 
as determined by scintillation counting of excised bands 
(lane 2). A 4-bp deletion designated -I-34A4, shown pre-
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Figure 2. Short transcripts are formed from several different 
mRNA promoters. (A) Structure of the different constructs used in 
the transfections. The promoter switches were performed using a 
unique Xho\ site engineered at position - 5 relative to the natural 
HIV-1 cap site. pPgl/R contains the rabbit p-globin promoter; 
pMLP/R contains the Ad2 major late promoter; pagl/R contains 
the human a-globin promoter. In the -I- 34A4 constructs, 4 bp was 
deleted at the unique Sac\ site in the sequences encoding the TAR 
element. (S) RNase Ti analysis of RNA from HeLa cells trans-
fected with palx72, pCGTat (lanes +) or pCG (lanes - ) , and the 
constructs indicated above the lanes. The probes were a98 and the 
probes corresponding to the different constructs. The region con-
taining the bands originating from protection of the a-globin probe 
(band labeled a and light bands just above) is from a lighter expo-
sure of the same gel, so that differences in intensities can be visu-
alized. (C) RNase Ti analysis of RNA from HeLa cells transfected 
with palx72, pCGTat (lanes -I-) or pCG (lanes - ) , the constructs 
indicated above the lanes, and an SV40 T Ag-expressing vector 
(pSYEori-; Hernandez and Lucito 1988). The probes were as in B. C is a much shorter exposure (10 hr) than S (5 days). (LONG EXP.) A 
long exposure of the region containing the L3 bands. Note that the sizes of the short transcripts vary depending on the exact site of 
initiation and the location of G residues in the probes, since RNase Tj cleaves only after G residues. In addition, in the -I-34A4 
constructs, each RNA species is shortened by 4 nucleotides, the extent of the deletion. 
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viously to debilitate the TAR element (deletion pD + 35/ 
+ 38 in Hauber and CuUen, 1988), abolished both the 
Tat-directed increase in long transcripts and the de-
crease in short transcripts (lanes 3 and 4), demonstrating 
that these effects are TAR dependent. The +34A4 dele-
tion did not, however, abolish the formation of short 
transcripts (Fig. 2B, lanes 3 and 4; note that the short 
transcripts are shortened by the extent of the deletion). 
Thus, as described previously (Selby et al. 1989), forma-
tion of the short transcripts is not dependent on a func-
tional TAR element. 
Replacement of the HIV-1 promoter by the p-globin 
promoter had no deleterious effect on either formation 
of short transcripts or Tat traijs-activation (Fig. 2B, lanes 
5 and 6; note that the sample in lane 6 is under-repre-
sented, as evidenced by the low a-globin signal). As ob-
served with the HIV-1 promoter, Tat diminished the 
amounts of short transcripts and increased the amounts 
of polyadenylated RNA (20-fold), and this effect was de-
pendent on TAR, but formation of the short transcripts 
itself was not dependent on an intact TAR element 
(lanes 7 and 8). The a-globin and Ad2 major late pro-
moter fusions also gave similar results (Fig. 2C, lanes 
13-16), even though SV40 T Ag was used to amplify the 
signal [note that T Ag did not affect the pattern of tran-
scription from the HIV-1 promoter, except to amplify 
the signal (Fig. 2C, lanes 9-12)]. The levels of Tat trans-
activation, however, were lower in these two cases 
(about fivefold). These results show that the formation 
of short transcripts is not dependent on HIV-1 promoter 
sequences upstream of position - 5, and, therefore, the 
short transcripts are unlikely to arise because the HIV-1 
upstream promoter sequences establish a transcription 
complex incapable of efficient elongation as is the case 
in the U2 snRNA promoter. 
The observation that coexpression of Tat both in-
creases the amounts of polyadenylated RNA and de-
creases the amounts of short transcripts prompted us to 
investigate whether in our assay system Tat increased 
the total levels of RNAs or only affected the proportion 
of short and long transcripts derived from the promoter. 
For this purpose, we quantitated the bands corre-
sponding to short and long transcripts by liquid scintil-
lation counting. Surprisingly, we found that the molar 
decrease in short transcripts was either larger or equiva-
lent to the molar increase in long transcripts (data not 
shown). It is often difficult to observe this correspon-
dence visually because the short transcripts are fre-
quently in a greater than 50-fold molar excess over the 
long transcripts. Thus, only a 20% decrease in the short 
transcripts can account for a 10-fold increase in the less 
abundant full-length transcripts. To assay directly for 
changes in total RNA levels, we performed primer ex-
tension analyses using a primer (designated tarloop 
primer) that anneals to sequences between +32 and 
+ 59 and therefore scores both short and long tran-
scripts. As an internal control, an a-globin RNA-specific 
primer was included. Figure 3A shows the results of 
analysis of RNA from both HeLa (Fig. 2B,C) and Jurkat 
transfections. In most of the constructs, the transcrip-
tion initiation sites were displaced compared to the ini-
tiation site in the HIV-1 R construct. The start sites cor-
responding to the longest primer extension product for 
each construct are indicated by a star in Figure 3B. They 
were consistently located close to the position (under-
lined nucleotides) of the start sites in the corresponding 
wild-type promoters, suggesting that their location is di-
rected by the upstream promoter elements. The striking 
observation was, however, that for each of the con-
structs the levels of total correctly initiated RNA in the 
presence of Tat were equal to or lower than the levels in 
the absence of Tat. Thus, in our assay. Tat did not in-
crease initiation of transcription. These observations are 
consistent with the results of Kao et al. (1987), but do 
not themselves establish the mechanism of Tat trans-
activation (see Discussion). 
Together, the experiments above demonstrate that 
formation of short transcripts and Tat trarzs-activation 
are not dependent on HIV-1 promoter sequences up-
stream of - 5, but instead can be observed with several 
different mRNA promoters. Furthermore, formation of 
the short transcripts is not dependent on an intact TAR 
element. 
A U2 snRNA promoter-R construct directs the 
formation of short transcripts and is tians-activated by 
Tat 
To assess the generality of short transcript formation 
and Tat trans-activation, we replaced the HIV-1 pro-
moter by the U2 promoter, which consists of a snRNA-
specific proximal element that is centered around - 50 
and is functionally equivalent to the TATA box of 
mRNA promoters, and an enhancer composed of an oc-
tamer motif adjacent to an Spl-binding site (for review, 
see Dahlberg and Lund 1988). In addition, we inserted a 
fragment containing the last 6 nucleotides of the Ul-
coding sequence and the Ul 3' box before the Ad2 poly-
adenylation site (constructs pU2/R/2 and pU2/R + 34A4/ 
2; Fig. 4A). The resulting constructs contain two consec-
utive 3'-end formation signals downstream of the HIV-1 
sequences: the Ul 3' box and the L3 polyadenylation 
site. Insertion of the Ul 3' box into the parent constructs 
pHIV-I/R and pHIV-l/R + 34A4 (see Fig. 4A, constructs 
pHIV-I/R/2 and pHIV-l/R + 34A4/2) did not have any ef-
fect on the pattern of RNA molecules generated from 
the HIV-1 promoter in the presence and absence of Tat 
(Fig. 4B, lanes 1-4), confirming that transcription com-
plexes initiated at mRNA promoters ignore the snRNA 
3' box termination signal (Hernandez and Weiner 1986; 
Neuman de Vegvar et al. 1986). In contrast, the U2 pro-
moter gave rise to new RNA species terminating at the 
Ul 3' box, as evidenced by the appearance of a typical 
doublet of bands in the RNase Tx protection pattern 
(lanes 5-8, bands labeled Ul 3' end). As expected, in the 
absence of Tat, very little RNA derived from the U2 pro-
moter extended through the 3' box to the polyadenyla-
tion site (lane 5, band labeled L3). But unexpectedly, this 
construct gave rise to short transcripts (lane 5, bands la-
beled St), suggesting that the element that directs the 
formation of short transcripts in the HIV-1 - 5 to +82 
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Figure 3. Primer extension analysis of RNA de-
rived from the different constructs. [A] Primer ex-
tension analysis of RNA from HeLa cells (lanes 
5-12) transfected with palx72, pCGTat (lanes +) or 
pCG (lanes - ) , the constructs indicated above 
the lanes, and the SV40 T Ag-expressing vector 
(pSVEori-), or from Jurkat cells (lanes 13-22] trans-
fected with the same constructs but in the absence 
of the SV40 T Ag-expressing vector (lanes 13-22). 
The primers were the tarloop primer and a primer 
complementary to a-globin RNA. (Lanes 1-4] Se-
quence ladders obtained by extension of the tarloop 
primer on the pHIV-l/R template in the presence of 
dideoxynucleotides. (Lanes 19-22] Long exposure of 
lanes 15-18]. [B] Sequence around the transcription 
start site in the indicated constructs. The sequences 
upstream of the Xho\ site are derived from the dif-
ferent promoters indicated in the constructs' 
names; the sequences downstream of the Xho\ site 
are HIV-1 sequences. Lowercase characters indicate 
nucleotides that differ from the wild-type sequence 
of the different promoters. Stars indicate the start 
sites corresponding to the longest primer extension 
products in A; underlined nucleotides indicate the 
positions of the start sites in the wild-type pro-
moters. 
sequences can act on transcription complexes derived 
from a wide variety of RNA polymerase II promoters. 
When the Tat protein was coexpressed with the U2 
promoter construct, the levels of short transcripts de-
creased, but the levels of RNAs ending at the 3 ' box did 
not increase; in fact, they were also diminished (Fig. 4B, 
lane 6). In contrast, the levels of polyadenylated RNAs 
increased significantly (10-fold, cf. lanes 6 and 5). This 
effect is TAR dependent, since it was abolished by the 
+ 34A4 mutation (lanes 7 and 8). This is a surprising re-
sult because it suggests that Tat can modify the elonga-
tion properties of a U2 transcription complex such that 
it can read through the 3 ' box termination signal, like an 
mRNA transcription complex. To exclude the separate 
possibility that Tat was trans-activating a cryptic, 
mRNA-type promoter overlapping with the U2 pro-
moter, we tested a construct in which the snRNA-spe-
cific proximal promoter element was debilitated by a 
clustered point mutation (pU2PE-/R/2; Fig. 4A). This 
construct produced no detectable RNA in the absence 
and presence of Tat (lanes 9 and 10), indicating that the 
effect of Tat seen with the wild-type U2 construct 
occurs through the snRNA promoter. Thus, the HIV-1 
sequences from - 5 to -1-82 can direct the formation of 
short transcripts from a very unusual RNA polymerase 
II promoter, and Tat can change the elongation proper-
ties of the U2 transcription complex such that it be-
comes similar to a mRNA complex and capable of 
reading through a 3 ' box. At present we do not know 
where this change in elongation properties occurs (e.g., 
before or after initiation of transcription). 
A U6 promoter-R construct directs the formation of 
short transcripts but is not trans-activated by Tat 
The RNA polymerase III U6 promoter is nearly identical 
in structure to the snRNA polymerase II promoters ex-
cept for the presence of a third element centered around 
- 2 5 , the A/T box, which determines the RNA poly-
merase III specificity of the promoter (Mattaj et al. 1988; 
Lobo and Hernandez 1989, and references therein). Since 
the essential promoter elements of the U6 gene lie 5' of 
the transcriptional start site, we could replace the HIV-1 
promoter with the U6 promoter without affecting the 
- 5 to -+-82 HIV-I sequences (construct pU6/R, Fig. 5A) 
and then test whether even an RNA polymerase III pro-
moter can direct formation of short transcripts and be 
trans-activated by Tat. RNA polymerase III transcrip-
tion is terminated by stretches of T residues; such a run 
of T residues is provided in pU6/R within the Ad2 frag-
ment, before the polyadenylation signal (see Fig. 5A). As 
shown in Figure 5B, lane 3, no major correctly initiated 
RNA species produced by this construct extended past 
the run of T residues, as expected. However, a large 
amount of short transcripts was also generated; these 
short transcripts were derived from the U6 promoter be-
cause mutation of the U6 proximal element resulted in a 
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loss of both full-length and short transcripts (lanes 5 and 
6). In sharp contrast to the RNA polymerase II promoter 
constructs, however, Tat had no effect on the ratio of 
long and short transcripts (Fig. 5B, cf. lanes 3 and 4 with 
the Tat traus-activation of the HIV-1 promoter construct 
in lanes I and 2), indicating that Tat is not able to affect 
transcription derived from an RNA polymerase III pro-
moter. These results show that formation of short tran-
scripts can be uncoupled from Tat t/^Jis-activation in at 
least two ways: by replacement of the HIV-1 promoter 
with an RNA polymerase III promoter, as shown in 
Figure 5, and by inactivation of the TAR element with 
the 4-34A4 mutation, as shown previously (Selby et al. 
1989) and in Figures 2 and 4 (and Fig. 6, below). 
The HIV-1 sequences from -5 to +82 promote an 
increase in steady-state RNA levels derived from 
different promoters 
The data described above show that the HIV-1 promoter 
region can be replaced by other RNA polymerase II pro-
moters without abolishing the formation of short tran-
scripts or Tat trans-activation. They are consistent with 
the HIV-1 LTR sequences from - 5 to -f 82 directing 3'-
end formation around position +60, except that they 
fail to explain why deletion of such a putative termi-
nator does not result in an increase of basal gene expres-
sion (Rosen et al. 1985; Cullen 1986; Peterlin et al. 1986; 
Wright et al. 1986; Muesing et al. 1987; Hauber and 
Cullen 1988). To resolve this paradox, we replaced the 
HIV-1 sequences from - 5 to -1-82 in the pHIV-l/R and 
ppgl/R constructs by the p-globin sequences naturally 
found from - 5 to -1-82 in the p-globin gene. The re-
sulting constructs contain either the HIV-1 promoter or 
the p-globin promoter fused to p-globin sequences, fol-
lowed by the Ad2 fragment containing the L3 polyaden-
ylation site (Fig. 6A). Thus, the p^gl/^gl construct does 
not contain any HIV-1 sequences. 
Figure 6B compares the RNAs produced by the con-
structs containing the - 5 to -1-82 HIV-1 sequences 
(pHIV-l/R, pHIV-l/R-h34A4, p(3gl/R, andppgl/R-h34A4; 
shown above in Fig. 2B) with the constructs containing 
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Figure 5. The U6 promoter directs the formation of short transcripts but 
is not tra/zs-activated by Tat. [A] Structure of the constructs. In pU6/R, the 
HIV-1 promoter is replaced by the human U6 promoter. In pU6PE~/R, the 
U6 proximal element is debilitated by a clustered point mutation (LS2; 
Lobo and Hernandez 1989). [B] RNase Ti analysis of RNA from Jurkat cells 
transfected with palx72, pCGTat (lanes +) or pCG (lanes - ) , and the con-
structs indicated above the lanes. The band labeled TTT corresponds to 
RNA correctly initiated at the U6 promoter and terminated at the run 
of Ts. 2 3 4 5 6 
the - 5 to +82 p-globin sequences (pHIV-1/pgl and 
pPgl/Pgl) in the presence and absence of Tat. Surpris-
ingly, the constructs containing the - 5 to +82 p-globin 
sequences (lanes 6 and 7 and 12 and 13) did not direct 
formation of short transcripts and the levels of polyade-
nylated RNA were low; indeed, they were slighty lower 
than those produced by the constructs containing the 
- 5 to +82 HIV-1 sequences in the absence of Tat (cf. 
lane 6 to lanes 2 and 4 and lane 12 to lanes 8 and 10, L3 
band). Thus, the total number of RNA molecules de-
rived from the pHIVl/(3gl and ppgl/^gl constructs were 
much lower than the total number of RNA molecules, 
short and long, derived from the pHIV-l/R, pHIV/ 
R + 34A4, ppgl/R, and ppgl/R + 34A4 constructs. Similar 
results were observed when the U6 promoter replaced 
the HIV-1 promoter in pHIV-l/R and pHIV-1/pgl (data 
not shown). 
These results suggest that the HIV-1 region from - 5 
to +82 not only directs formation of the short tran-
scripts but also activates the very transcription that re-
sults in their synthesis. However, an altemative inter-
pretation was that the transcripts derived from the con-
structs containing the - 5 to +82 p-globin sequences 
were much less stable than those derived from the con-
structs containing the - 5 to +82 HIV-1 sequences, 
perhaps because they could not fold into a stable stem-
and-loop structure. To address this question, we re-
placed the HIV-1 sequence from position +2 to +59 in 
pHIV-l/R with a synthetic DNA fragment corre-
sponding to the +2 to +59 sequence read in a 3' to 5' 
direction ( + 59, +58, +57, etc.), to generate the clone 
pHIV-1/RAT. As indicated in Figure 6C, the RNA en-
coded by this sequence can potentially fold into a sec-
ondary structure of very similar stability as the stem-
and-loop structure assumed by HIV-1 RNA. However, 
hke pHIV-1/pgl, pHIV-1/RAT failed to produce detect-
able amounts of short transcripts and produced low 
levels of polyadenylated RNA (Fig. 6B, lane 1), sug-
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gesting that the large amounts of short transcripts ob-
served in the presence of the - 5 to +82 HIV-1 se-
quences do not arise solely because of folding of the 
RNA into a stable stem-and-loop structure. Thus, a large 
decrease in the total amount of RNA was observed with 
two substitutions of the - 5 to +82 HIV-1 sequences 
(Pgl and RAT), one of them encoding a potential RNA 
secondary structure very similar to that encoded by the 
wild-type HIV-1 R region. 
The HIV-1 sequences from -5 to +82 stimulate 
transcription from RNA polymerase II and III 
promoters in a run-on assay 
To determine directly whether the - 5 to +82 HIV-1 re-
gion increases the steady-state levels of short RNAs by 
increasing the rate of transcription, we performed 
"run-on" experiments. Such experiments measure the 
amounts of nascent RNA molecules produced on a given 
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portion of the DNA template and thus reflect the den-
sity of RNA polymerases in that template region. COS 
cells were transfected with the reference a-globin gene 
and test constructs either containing the - 5 to +82 
HIV-1 region or with these sequences substituted by [3-
globin sequences. Twenty-four hours after transfection, 
the cells were permeabilized and exposed for 6 min to 
[cj-32pjuTP. The resulting radioactive RNA was hybrid-
ized to single-stranded probes immobilized on filters 
that were directed to the sense (ss-l-) or antisense ( s s - ) 
strands of the - 5 to +82 HIV-1 region (probe mpl8/R) 
or the - 5 to +82 p-globin region (probe mpl8/pgl). 
Probes that hybridize to the sense and antisense strands 
of the a-globin reference gene (probes mp l8 / a ss+ and 
ss - ) were also included. The filters were then treated 
with RNase A, and the resistant signal was visualized by 
autoradiography. 
Figure 7 shows the results of such an experiment for 
two pairs of constructs containing an RNA polymerase 
n promoter (pHIV-I/R and pHIV-l/(3gl, ppgl/R and pPgl/ 
3gl) and one pair of constructs containing an RNA poly-
merase III promoter (pU6/R and pU6/3gl). In cells trans-
fected with the wild-type pHIV-l/R construct, strand-
specific promoter proximal transcription was readily 
detected by the corresponding probe (mpl8/R ss +, panel 
1). In contrast, when the - 5 to +82 HIV-1 sequences in 
this construct were replaced by the p-globin sequences 
(construct pHIV-1/pgl), the signal hybridizing to the cor-
responding probe (mpl8/(3gl ss + ) was undetectable 
(panel 2). The a signals were nearly identical in both 
samples (probe mpI8 /a ss + , panels 1 and 2], indicating 
that the transfection efficiencies were similar. Because 
the levels of transcription in the absence of the - 5 to 
+ 82 HIV-1 sequences were not detectable, the magni-
tude of the transcription stimulation by these sequences 
cannot be ascertained but may be very large. A similar 
result was obtained with the constructs pPgl/R and 
ppgl/pgl (panels 3 and 4). Significantly, the HIV-1 - 5 to 
+ 82 region also stimulated transcription from the RNA 
polymerase III U6 promoter about fourfold (cf. panels 5 
and 6), indicating that it contains an activator of both 
RNA polymerase II and RNA polymerase III transcrip-
tion. As described previously by others in a similar assay 
(Kao et al. 1987), the presence of Tat did not increase 
promoter proximal transcription of the TAR-containing 
constructs (data not shown). These results demonstrate 
that the HIV-l region from - 5 to +82 contains an acti-
vator of transcription. They are consistent with the ob-
servations that substitution of these sequences results in 
a complete loss of the short transcripts and therefore a 
loss in total RNA (Fig. 6B). Together, the run-on anal-
yses and the RNase Tj protection analyses suggest that 
the HIV-1 sequences between - 5 and +82 contain an 
inducer of short transcripts, which we refer to as 1ST. 
Discussion 
The 1ST described here has a remarkably broad activity, 
since it is capable of inducing short transcripts from very 
different types of RNA polymerase II promoters (mRNA 
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Figure 7. The HIV-l sequences from - 5 to +82 increase the 
amounts of newly transcribed RNA from an RNA polymerase II 
and an RNA polymerase III promoter. COS cells were trans-
fected with TTSVHPa2 (Treisman et al. 1983), a plasmid carrying 
the a-globin gene and an SV40 origin of replication, and the 
constructs indicated above the panels. The cells were perme-
abilized and incubated with [a^^PJUTP for 6 min. RNA was ex-
tracted and hybridized to different single-stranded probes im-
mobilized on filters. The mpl8/R probes contain the strand hy-
bridizing to the sense (labeled ss +) or antisense (labeled ss - ) 
strand of the HIV-l sequences from - 5 to +82, the mpl8/pgl 
probes contain the antisense and sense strands of the rabbit p-
globin gene from - 5 to +82, and the mpl8/a probes contain 
the antisense or sense strands of the whole human a-globin 
gene from -570 to 90 nucleotides past the polyadenylation 
site. 
and snRNA) and even from an RNA polymerase III pro-
moter. The activity of 1ST does not affect significantly 
the normal promoter activity that results in the syn-
thesis of full-length transcripts, but rather superimposes 
itself on the normal activity of the promoter. 1ST in-
creases transcription as measured by run-on experi-
ments. This suggests that 1ST functions by inducing the 
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formation of unusual transcription complexes that are, 
like the Ul and U2 snRNA transcription complexes, not 
capable of efficient elongation. 
Where is 1ST located} 
Our experiments localize 1ST in the region extending 
from - 5 to +82 relative to the HIV-1 cap site. 1ST could 
be a DNA element. Several protein-binding sites located 
downstream of the HIV-1 transcriptional start site have 
been visualized by DNase I footprinting (Garcia et al. 
1987; Jones et al. 1988; Wu et al. 1988a,b), and some of 
these binding sites correlate with sequences required for 
efficient transcription in vivo and in vitro (Garcia et al. 
1987; Jones et al. 1988). For example, Jones et al. (1988) 
identified a motif repeated three times between posi-
tions - 3 and +22, which binds a factor designated 
LBP-1, and showed that a triple-site mutation that mod-
ifies the three LBP-1 binding sites severely reduces 
transcription in vitro. Primer extension, the assay used 
to measure transcription in these experiments, scored 
both short and long transcripts but could not distinguish 
between the two types of RNA. Thus, it is possible that 
the stimulation of transcription directed by the LBP-1 
binding sites resulted solely in the formation of short 
transcripts, and that the LBP-1 binding sites represent 
1ST. 1ST could also conceivably be an RNA element, and 
its activity might be mediated through one of the cel-
lular factors that bind to the 5'-end region of HIV-1 RNA 
(Gatignol et al. 1989; Gaynor et al. 1989; Marciniak et 
al. 1990). 1ST is, however, clearly distinct from TAR, the 
target for Tat trans-activation, since a mutation (+ 34A4) 
that debilitates TAR does not affect the formation of 
short transcripts. Localizing the 1ST element is compli-
cated by the fact that mutations downstream of the start 
site of transcription alter the sequence of the RNA and 
thus may change its stability. The precise localization of 
1ST will therefore require the analysis of mutations that 
do not affect the secondary structure in the +2 to +59 
region by both run-on and RNase Tj protection analyses. 
How does 1ST function} 
A question related to the localization of 1ST is, how does 
1ST function. 1ST is an activator of transcription, as 
demonstrated by the run-on experiments in Figure 7. 
However, most, if not all, of the resulting RNAs are 
short, as indicated by the RNase Ti protection analyses. 
Thus, 1ST might consist of both an activator of tran-
scription and a 3'-end formation element. However, a 
simpler model is that 1ST directs the formation of weak 
transcription complexes that are unable to elongate effi-
ciently. In this model, the short RNAs would be the 
remnants, stabilized by the stem-and-loop structure, of 
exonucleolytic degradation of longer, randomly termi-
nated RNA molecules. Random termination of tran-
scription would occur relatively close to the start site of 
transcription, since 1ST does not increase significantly 
the production of polyadenylated RNA and, in our con-
structs, the polyadenylation site is only 236 nucleotides 
away from the start site of transcription. Although the 
secondary structure at the 5' end of HIV-1 RNAs is not 
sufficient for the generation of short transcripts (Fig. 6, 
pHIV-1/RAT construct), it probably stabilizes the prod-
ucts of abortive transcription and therefore may be a key 
requirement for their detection. 
Effects of Tat on initiation and elongation of 
transcription 
As described previously (Rosen et al. 1985; CuUen 1986; 
Peterlin et al. 1986; Wright et al. 1986; Muesing et al. 
1987), we find that Tat can increase the production of 
full-length RNAs from a wide variety of promoters, al-
though with different efficiencies. Tat cannot, however, 
affect an RNA polymerase III transcription complex. In 
our transient transfection assay, the increase in polyade-
nylated RNA in the presence of Tat is accompanied by a 
decrease in the short transcripts. Strictly, this effect 
could result from Tat stabilizing the polyadenylated 
RNAs and destabilizing the short RNAs. However, con-
sistent with the observations of Hauber et al. (1987), we 
failed to detect any effect of Tat on RNA stability as 
measured after blocking transcription with actinomycin 
D (data not shown; see Materials and methods). The in-
crease in polyadenylated RNAs and decrease in short 
RNAs could also result from transcription antitermina-
tion by Tat around position + 60, as proposed originally 
by Kao et al. (1987). However, our data do not demon-
strate that the long transcripts originate from the short 
ones. Instead, our analysis of the pU2/R construct, 
which shows that in the presence of Tat new U2 tran-
scription complexes capable of reading through the 3' 
box are generated, suggests another model—that Tat di-
rects the formation of mRNA-type transcription com-
plexes, which, unlike the snRNA and IST-directed tran-
scription complexes, are capable of efficient elongation 
through long distances. Thus, Tat action can be de-
scribed as increasing the rate of initiation of mRNA-type 
transcription complexes, consistent with the observa-
tion that Tat affects both initiation and elongation of 
transcription (Laspia et al. 1989). 
Possible role of the short transcripts in infected cells 
An intriguing question is the role 1ST plays in Tat trans-
activation. Recent results suggest that 1ST is not abso-
lutely required for Tat trans-activation. Indeed, con-
structs in which most of the - 5 to +82 HIV-1 se-
quences have been replaced by sequences encoding the 
RNA-binding sites for the Rev or MS2 coat proteins can 
be trans-activated by Tat-Rev or Tat-MS2 coat fusion 
proteins (Selby and Peterlin 1990; Southgate et al. 1990). 
Instead, the properties of 1ST suggest that this element 
may have a regulatory role in the virus. 
The TAR element performs its function at the level of 
nascent RNA (Berkhout et al. 1989); it is, therefore, 
likely to trans-activate the very promoter from which it 
is synthesized. This implies that a given DNA template 
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must be transcribed to be responsive to Tat. In this con-
text, 1ST provides a mechanism to allow an HIV-1 pro-
vims to be highly responsive to Tat without itself ex-
pressing any full-length mRNAs or proteins. The Tat 
protein, which is a viral product, could be provided by 
another provirus in the same cell or perhaps even by 
pro viruses in other cells. Indeed, Tat is secreted into the 
medium by HIV-1-infected cells (Ensoli et al. 1990) and 
might conceivably be taken up by neighboring cells. 
Once released from the transcription complex, short 
transcripts might also, under certain circumstances, 
down-regulate Tat trans-activation by sequestering Tat 
molecules. 1ST may, then, be an important player in the 
switch between latency and productive infection. 
Because 1ST depends only on cellular factors for its 
function, it is likely to have cellular equivalents and 
may be just one example of a family of transcriptional 
elements that activate the formation of nonprocessive 
transcription complexes. This raises the possibility that 
many cellular inducible genes direct, in the absence of 
the inducer, the synthesis of large amounts of prema-
turely truncated and unstable RNA molecules and are 
regulated in part by transcription factors that change the 
elongation properties of such transcription complexes at 
the promoter. Thus, the HIV-1 LTR may be unique only 
in that the products of such abortive transcription are 
stable (and thus detectable), and are probably themselves 
involved in transcription regulation by Tat. 
Materials and methods 
Plasmid constructions 
pHIV-l/R is a derivative of pUCl 18 with a large insert between 
the £coRI and Hindlll sites of the polylinker. The insert con-
sists of (1) a duplicated SV40 early polyadenylation site at 
which RNAs derived from cryptic promoters within the vectors 
are presumably cleaved and polyadenylated (Hernandez and Lu-
cito 1988), (2) HIV-1 sequences from -138 to -1-82 relative to 
the cap site but modified from - 10 to - 6 by a clustered point 
mutation that creates a Xhol restriction site from - 10 to - 5, 
(3) a fragment derived from Ad2 (nucleotides 22,305 to 22,491) 
carrying the L3 polyadenylation site, (4) a 214-nucleotide 
Hindl-Pvull fragment derived from pBSM13(-l-) carrying the 
T3 promoter, and (5) an SV40 fragment (nucleotides 5171 to 
105) carrying the origin of repHcation (but not the SV40 en-
hancer). The promoter fragments replacing the HIV-1 promoter 
sequences from an £coRI site (see Fig. lA) at position - 140 to 
the Xhol site were as follows: for ppgl/R, a Xholl-PvuW. rabbit 
p-globin promoter fragment extending from - 426 to - 9 rela-
tive to the cap site (the p3gl/R clone used in Fig. 6 has one 
additional nucleotide at the junction between p-globin and 
HIV-1 sequences GGGCAGCTCGAGTACTG as compared to 
the clone used in Fig. 2, GGGCAGTCGAGTACTG, and this 
results in the generation of two transcriptional start sites); for 
pMLP/R, an Ad2 fragment extending from - 188 to - 12 rela-
tive to the major late cap site; for pagl/R, a SssHII human a-
globin promoter fragment extending from -486 to -14 rela-
tive to the cap site; for pU2/R, a human U2 promoter fragment 
extending from - 247 to - 5 relative to the cap site; for pU6/R, 
a human U6 promoter fragment extending from -245 to - 11. 
In pHrV-l/R/2 and pU2/R/2, a fragment derived from pU6/Hae/ 
RA.2 (Lobo and Hernandez 1989) containing the last 6 nucleo-
tides of the coding Ul region and 90 nucleotides of Ul 3'-
flanking sequences was inserted between the HIV-1 sequences 
and the Ad2 fragment, at the BamHl site. The 4- 34A4 mutation 
was introduced into several of the constructs by cleavage with 
Sad, digestion of the 3' overhangs with Klenow fragment, and 
religation. The clustered point mutations in the proximal ele-
ments of the U2 and U6 promoters were introduced by oligonu-
cleotide-directed mutagenesis and were equivalent to the 
LS-34/ -43 (Hernandez and Lucito 1988) and LS2 (Lobo and 
Hernandez 1989) mutations described previously. 
To generate pHIV-1/pgl, rabbit p-globin sequences from - 4 
to + 82 were amplified from a plasmid by the polymerase chain 
reaction (PCR) with two primers; the upstream primer con-
tained an Xhol site, the downstream primer contained a BamHl 
site, such that after digestion with Xhol and BamHl, the frag-
ment could be inserted by "sticky-end" ligation into the 
pHlV-l/R construct to replace the HIV-1 - 5 to -1-82 sequences 
(see Fig. lA for the location of the Xhol and BamHl restriction 
sites). To construct p3gl/|3gl, rabbit p-globin sequences from 
- 353 to -I- 82 were amplified and cloned by similar methods as 
described above between the £coRI and BamHl sites. pHIV-1/ 
RAT was constructed from two oligonucleotides; the upper-
strand oligonucleotide had the sequence GGAACTCGAG-
TACTGCCAAGGGATCGATCGGTCTCTCGAGGGTCCG-
AGTCTAG, and the lower-strand oligonucleotide had the 
sequence AAAAGGATCCCCAGCTTTATTGAGGCTTAAG-
CAGTGCCAGAGAGACCAATCTGGTCTAGACTCGGAC-
CCTCGA. The two oligonucleotides were annealed, the ends 
were filled in with Klenow, and the resulting fragment was di-
gested with BamHl and partially digested with Xhol, and then 
cloned by sticky-end ligation into HIV-l/R to replace the - 5 to 
-1-82 HIV-1 sequences. 
The pCG expression vector has been described previously 
(Tanaka and Herr 1990). To construct pCGTat, Tat cDNA se-
quences from the initiation to the termination codon were am-
plified by PCR with an upstream primer containing an Xhal site 
and a downstream primer containing a BamHl site. The re-
sulting fragment was cleaved with Xhal and BamHl and cloned 
by sticky-end ligation into pCG. All clones were verified by se-
quencing. 
Transfections 
lurkat, HeLa, and COS cells were transfected by electropora-
tion. lurkat cells were grown in RPMI-1640 with 10% fetal calf 
serum, 10 mM HEPES (pH 7.4), and 2 mM L-glutamine, to a den-
sity of 1 X 10* to 1.5 X 10* cells per milliliter. For each sample, 
cells from 15 ml of culture were collected by centrifugation and 
resuspended in 250 |xl of medium. A mixture of plasmids con-
taining 7 .^g of the test plasmid, 1 or 2 |xg of palx72, 0.5 |xg of 
pCG or pCGTat, and calf thymus DNA carrier to a total of 20 
fig in 20-30 |xl of TE (10 mM Tris/HCl at pH 7.5, 1 mM EDTA) 
was added to the cells. The mixture was incubated on ice for 10 
min, transferred to a Gene Pulser Cuvette (Bio-Rad, 0.4-cm 
electrode gap), and electroporated by a pulse of 200 V, 960 {iP in 
a Gene Pulser (Bio-Rad). The cells were then transferred to 
10-cm dishes containing 10 ml of medium, and RNA was col-
lected 24 hr later. HeLa cells and COS cells were grown in 
DMEM supplemented with 10% fetal calf serum to a density of 
80-90%. For each sample, the cells from one 10-cm dish were 
trypsinized, resuspended in 250 .^1 of medium, and electropor-
ated as described above. Where indicated in the figure legends, 3 
|xg of pSVEori-, an SV40 T Ag-expressing vector (Hernandez 
and Lucito 1988), was included in the transfections. 
Determination of RNA stabihties 
To determine the stabilities of the different RNA species, 
lurkat cells were transfected as described above. Twenty-two 
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hours after transfection, actinomycin D was added to the me-
dium to a final concentration of 2.5 |xg/ml to block all tran-
scription. An aliquot of cells was collected immediately, and 
further aliquots were collected after different periods of time. 
RNA was analyzed by RNase Ti as described below. The half-
lives determined in such experiments were >7 hr for both the 
short transcripts and polyadenylated RNAs. In contrast, RNAs 
ending at the Ul 3' box or at the run of T residues were quite 
unstable, with a half-life of 1 hr. The half-lives were not 
changed in the absence or presence of Tat. 
RNase Tj mapping and piimei extension 
RNA was collected as described in Hernandez and Lucito 
(1988). The RNase Tj protections and the primer extensions 
were performed as described in Lobo and Hernandez (1989). To 
generate the riboprobes, each different construct was cleaved 
with £coRI and used as a template for bacteriophage T3 RNA 
polymerase. Gels were quantitated by liquid scintillation 
counting of excised bands and normalization to the a-globin 
signal from the internal reference. 
Run-on analyses 
Five 10-cm dishes of 80-90% confluent COS cells were trans-
fected separately by electroporation as described above. The 
cells were then mixed and transferred to three 15-cm dishes. 
Twenty-four hours after transfection, the cells were permeabi-
lized by treatment with digitonin according to Ucker and Ya-
mamoto (1984). Permeabilized cells were resuspended in 100 ,^1 
of buffer B (50 mM HEPES at pH 8, 5 mM MgClj, 0.5 mM DTT, 
25% glycerol). The reaction was started by the addition of 35 |JL1 
of [a-32p]UTP (350 ixCi) at a sp. act. of 3000 Ci/mmole, and 200 
|xl of a solution containing 0.3 M NH4CI, 0.5 mM HEPES (pH 8), 
6 mM MgO acetate, 4 mM MgClj, 4 mM DTT, 0.8 mM ATP, 
CTP, GTP, and 0.5 |xM UTP, and the mixture was incubated for 
6 min at 30°C. The reaction was terminated by the addition of 
600 M-l of a solution containing 0.5 M NaCl, 50 mM MgClj, 2 
mM CaClj, 10 mM Tris/HCl (pH 7.4), 5 mM DTT, 120 units/ml 
of DNase I, and 2 mg/ml of a-amanitin. After 10 min at 30°C, 
200 JJLI of SDS/Tris buffer was added (5% SDS, 0.5 M Tris/HCl at 
pH 7.4, 0.125 M EDTA), and the RNA was extracted as de-
scribed by Greenberg and Bender (1987). 
The radiolabeled RNA (7 x 10^  to 10 x 10^  cpm) was hybrid-
ized to single-stranded DNA probes immobilized on filters 
(Biodyne transfer membrane) in 1 x Denhardt's solution con-
taining 100 (JLg/ml of denatured salmon sperm DNA, 0.5% SDS, 
and 6 x SSC for 48 hr at 55°C. The filters were washed, treated 
with RNase A [10 |xg/ml in 6 x SSC) for 30 min at 37°C, rinsed 
in 6 x SSC at 37°C, blotted dry, and autoradiographed. The re-
sults were quantitated by liquid scintillation counting of the 
slots and normalization to the a-globin RNA signal from the 
internal reference. 
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